CPRX — Catalyst Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Catalyst Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	191	298	138	518	709
Net Total Accounts Receivable
Net Total Receivables	6.62	10.4	53.5	65.5	128
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	210	321	219	624	894
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.98	3.62	3.7	3.58	2.97
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	238	376	470	851	1,104
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	27.1	57.6	76.1	121	147
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	31	75.2	82.2	124	150
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	207	300	388	728	954
Total Liabilities & Shareholders' Equity	238	376	470	851	1,104
Total Common Shares Outstanding